Laboratory of Food & Health, Research Group on Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Murcia 30100, Spain.
J Agric Food Chem. 2023 Mar 8;71(9):4029-4035. doi: 10.1021/acs.jafc.2c08889. Epub 2023 Feb 25.
We aimed to elucidate the gut bacteria that characterize the human urolithin metabotypes A and B (UM-A and UM-B). We report here a new bacterium isolated from the feces of a healthy woman, capable of producing the final metabolites urolithins A and B and different intermediates. Besides, we describe two gut bacterial co-cultures that reproduced the urolithin formation pathways upon in vitro fermentation of both UM-A and UM-B. This is the first time that the capacity of pure strains to metabolize ellagic acid cooperatively to yield urolithin profiles associated with UM-A and UM-B has been demonstrated. The urolithin-producing bacteria described herein could have potential as novel probiotics and in the industrial manufacture of bioactive urolithins to develop new ingredients, beverages, nutraceuticals, pharmaceuticals, and (or) functional foods. This is especially relevant in UM-0 individuals since they cannot produce bioactive urolithins.
我们旨在阐明能够表征人类尿石素代谢型 A 和 B(UM-A 和 UM-B)的肠道细菌。在这里,我们报告了一种从健康女性粪便中分离出来的新细菌,该细菌能够产生最终代谢产物尿石素 A 和 B 以及不同的中间产物。此外,我们还描述了两种肠道细菌共培养物,它们能够在体外发酵 UM-A 和 UM-B 时重现尿石素的形成途径。这是首次证明纯菌株能够协同代谢鞣花酸以产生与 UM-A 和 UM-B 相关的尿石素谱。本文描述的产尿石素细菌具有作为新型益生菌和在生物活性尿石素的工业制造中的应用潜力,以开发新的成分、饮料、营养保健品、药物和(或)功能性食品。这在 UM-0 个体中尤为重要,因为他们不能产生生物活性尿石素。